Abstract:Highlights • mGluR5 PAM pre-treatment prevents MK-801 induced increased extracellular glutamate. • mGluR5 PAM does not affect mPFC extracellular glutamate when given alone. • mGluR5 PAM may restore cognitive function by regulating mPFC glutamate. • Targeting mGluR5 with PAMs may treat neuropsychiatric disorder impairments. Potentiation of metabotropic glutamate receptor subtype 5 (mGluR5) function produces antipsychotic-like and pro-cognitive effects in animal models of schizophrenia and can reverse cognitive deficits induced by N-methyl-D-aspartate type glutamate receptor (NMDAR) antagonists. However, it is currently unknown if mGluR5 positive allosteric modulators (PAMs) can modulate NMDAR antagonist-induced alterations in extracellular glutamate levels in regions underlying these cognitive and behavioral effects, such as the medial prefrontal cortex. We therefore assessed the ability of the mGluR5 PAM, 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl) benzamide (CDPPB), to reduce elevated extracellular glutamate levels induced by the NMDAR antagonist, dizocilpine (MK-801), in the medial prefrontal cortex. Male Sprague-Dawley rats were implanted with a guide cannula aimed at the medial prefrontal cortex and treated for ten consecutive days with MK-801 and CDPPB or their corresponding vehicles. CDPPB or vehicle was administered thirty minutes before MK-801 or vehicle each day. On the final day of treatment, in vivo microdialysis was performed, and samples were collected every thirty minutes to analyze extracellular glutamate levels. Compared to animals receiving only vehicle, administration of MK-801 alone significantly increased extracellular levels of glutamate in the mPFC. This effect was not observed in animals administered CDPPB before MK-801, nor in those administered CDPPB alone, indicating that CDPPB decreased extracellular glutamate release stimulated by MK-801. Results indicate that CDPPB attenuates MK-801 induced elevations in extracellular glutamate in the medial prefrontal cortex. This effect of CDPPB may underlie neurochemical adaptations associated with the pro-cognitive effects of mGluR5 PAMs in rodent models of schizophrenia. Graphical abstract Download: Download high-res image (95KB) Download: Download full-size image

Metabotropic glutamate receptor 5 upregulates surface NMDA receptor expression in striatal neurons via CaMKII

Integrins Regulate Nmda Receptor-Mediated Synaptic Currents

Activation of mGluR5 Attenuates NMDA-Induced Neurotoxicity through Disruption of the NMDAR-PSD-95 Complex and Preservation of Mitochondrial Function in Differentiated PC12 Cells

Mglur5 Promotes the Differentiation of Rat Neural Progenitor Cells into Cholinergic Neurons and Activation of Extracellular Signal-Related Protein Kinases

Metabotropic Glutamate Receptor 5 Promotes Proliferation of Human Neural Stem/Progenitor Cells with Activation of Mitogen-Activated Protein Kinases Signaling Pathway in Vitro

Mglur1 and Mglur5 Synergistically Control Cholinergic Synaptic Transmission in the Thalamic Reticular Nucleus

Involvement of Metabotropic Glutamate Receptor 5 in Cardiomyocyte Differentiation from Mouse Embryonic Stem Cells.

Adenosine A₂A receptors permit mGluR5-evoked tyrosine phosphorylation of NR2B (Tyr1472) in rat hippocampus: a possible key mechanism in NMDA receptor modulation

Activation of group I metabotropic glutamate receptors regulates the excitability of rat retinal ganglion cells by suppressing Kir and I h

Metabotropic glutamate receptor mGluR5 in astrocytes: pharmacological properties and agonist regulation

Glycine Potentiates AMPA Receptor Function Through Metabotropic Activation of GluN2A-Containing NMDA Receptors.

Protein Kinase C-Mediated Phosphorylation and 2-1 Interdependently Regulate NMDA Receptor Trafficking and Activity

Metabotropic glutamate receptors in the main olfactory bulb drive granule cell-mediated inhibition

Signal Transduction Induced by Mglur 1/5

Molecular mechanisms of group I metabotropic glutamate receptor mediated LTP and LTD in basolateral amygdala in vitro

Phosphorylation of group I metabotropic glutamate receptors (mGluR1/5) in vitro and in vivo.

Mglur5 is Involved in Proliferation of Rat Neural Progenitor Cells Exposed to Hypoxia with Activation of Mitogen-Activated Protein Kinase Signaling Pathway

Regulation of NMDA receptor trafficking and gating by activity-dependent CaMKIIα phosphorylation of the GluN2A subunit

N-methyl-D-aspartate Receptor-Dependent Long-Term Potentiation in CA1 Region Affects Synaptic Expression of Glutamate Receptor Subunits and Associated Proteins in the Whole Hippocampus.

Differential Regulation of AMPA Receptor GluA1 Phosphorylation at Serine 831 and 845 Associated with Activation of NMDA Receptor Subpopulations

mGluR5 Positive Allosteric Modulation Prevents MK-801 Induced Increases in Extracellular Glutamate in the Rat Medial Prefrontal Cortex